title: [Protective effects of rhein on hepatic progression in HBV-transgenic mice with nonalcoholic steatohepatitis induced by a high-fat diet].
abstract: OBJECTIVE
  To investigate the beneficial effects of Rhein (RH) on hepatic progression in hepatitis B virus (HBV)-transgenic mice with nonalcoholic steatohepatitis induced by a high-fat (HF) diet.
  
  
  METHODS
  A mice model of HBV chronic infection concomitant with liver steatosis was induced by a HF diet in 4-week old HBV-transgenic mice for 16 weeks (n = 130). Thereafter, the mice were divided randomly into control group (back to normal chow), model group (continuing HF diet), RH group [continuing HF diet and administering with 120 mg/(kg x d) RH by gavage] and Essentiale group [continuing HF diet and administering with 69.2 mg/(kg x d) Essentiale by gavage] with 30 mice in each, and were sacrificed at the end of 24-week and 48-week respectively. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), triglyceride (TG) and fasting plasma glucose (FPG) were measured by an automatic biochemical analyzer, and serum HBV-DNA was determined with qPCR. Hepatic histology was evaluated by HE staining with a light microscope.
  
  
  RESULTS
  (1) An histological change composed of steatosis, lymphocytes intralobular infiltration and ballooning was observed after 48 weeks feeding of HF diet, in part mimicking that of NASH patients as evidenced by a NAFLD activity score (NAS) of 3.58 +/- 1.44 points. (2) Histologically, the NAS of model group was higher than that of control group at both time points. RH failed to lessen NAS whereas Essentiale improved the NAS at 48-week. (3) Serum levels of TC, TG and FPG were significantly different between 4 groups at 24-week, with a comparable low value in both RH and Essentiale group. A similar change was evident at 48-week. (4) In terms of HBV viral load, a significantly lower level in Essentiale group than the others was observed at both time points.
  
  
  CONCLUSIONS
  HF diet feeding is able to induce a mouse model of HBV chronic infection concomitant with NASH. RH is effective in alleviating the glucose and lipid metabolism but ineffective in improving the hepatic histology in this model, in contrast, backing to normal chow achieved a better effect in this aspect.
authors.forename: Dong-Xue
authors.initials: DX
authors.lastname: Bian
authors.forename: Jing
authors.initials: J
authors.lastname: Liu
authors.forename: Lu
authors.initials: L
authors.lastname: Lu
authors.forename: Hong
authors.initials: H
authors.lastname: Liu
authors.forename: Jian-Chun
authors.initials: JC
authors.lastname: Guo
authors.forename: Wen-Jun
authors.initials: WJ
authors.lastname: Yang
authors.forename: Yin-Lan
authors.initials: YL
authors.lastname: Liu
authors.forename: Yan
authors.initials: Y
authors.lastname: Luo
authors.forename: Zhen-Jie
authors.initials: ZJ
authors.lastname: Zhuang
authors.forename: Jian-Yu
authors.initials: JY
authors.lastname: Chen
authors.forename: Jun-Ping
authors.initials: JP
authors.lastname: Shi
authors.forename: Yun-Hao
authors.initials: YH
authors.lastname: Xun
mesh_terms: D000818:Animals; D000880:Anthraquinones / Q000008:administration & dosage*; D059305:Diet, High-Fat / Q000009:adverse effects; D004195:Disease Models, Animal; D018450:Disease Progression; D005234:Fatty Liver / Q000150:complications / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D005260:Female; D005947:Glucose / Q000378:metabolism; D006515:Hepatitis B virus / Q000502:physiology*; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000378:metabolism / Q000821:virology; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008822:Mice, Transgenic; D065626:Non-alcoholic Fatty Liver Disease
chemical_list: D000880:Anthraquinones; D005947:Glucose; C020491:rhein